Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F62L9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,956
Award facts
- Contract value 100% obligated
- $17,955.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,955.63 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease. This firm fixed-price delivery order was awarded on December 2, 2025, with an ultimate completion date of December 3, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion contract vehicle that runs through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. As a prime contractor on this major pharmaceutical IDC, AmerisourceBergen supplies an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. The company's demonstrated capability to fulfill competitive federal procurement requirements and manage large-scale pharmaceutical distribution operations positions it as a critical vendor for the military's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F62L9?
SPE2DR26F62L9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F62L9 worth?
The government has obligated $17,956 on SPE2DR26F62L9.
Is contract SPE2DR26F62L9 an order under another contract?
Yes. SPE2DR26F62L9 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F62L9 competed?
The extent of competition for SPE2DR26F62L9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award